OPNT - Opiant Pharmaceuticals EPS beats by $0.09 beats on revenue May, 11 2021 04:15 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals (OPNT): Q1 GAAP EPS of -$0.66 beats by $0.09.Revenue of $6.39M (+49.3% Y/Y) beats by $0.7M.Press Release For further details see: Opiant Pharmaceuticals EPS beats by $0.09, beats on revenue